Renin release in response to renin system blockade: Activation of the renin system in type 1 diabetes mellitus

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System

Volumn 6, Issue 2, 2005, Pages 78-83

  Stevanovic, Radomir D ^a,c   Price, Deborah A ^a   Lansang, M Cecilia ^a   Fisher, Naomi D L ^a   Laffel, Lori M B ^b   Hollenberg, Norman K ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c NONE   (United States)

Author keywords

Diabetes; Renal plasma flow; Renin

Indexed keywords

ALDOSTERONE; ANGIOTENSIN; ANGIOTENSIN RECEPTOR ANTAGONIST; CANDESARTAN; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; INSULIN; RENIN; SODIUM;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DRUG DOSE REGIMEN; DRUG RESPONSE; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FUNCTION; KIDNEY PLASMA FLOW; MALE; PLASMA RENIN ACTIVITY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RENIN RELEASE; SODIUM BALANCE; STATISTICAL ANALYSIS;

EID: 28244445620     PISSN: 14703203     EISSN: None     Source Type: Journal    
DOI: 10.3317/jraas.2005.013     Document Type: Article

References (21)

1. Remuzzi G, Ruggenenti P, Perico N. Chronic Renal Diseases: Renoprotective Benefits of Renin-Angiotensin System Inhibition. Ann Intern Med 2002;136(8):604-15.
2. Brenner BM, Cooper ME, de Zeeuw D et al. The losartan renal protection study -rationale, study design and baseline characteristics of RENAAL (Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan). JRAAS 2000;1(4):328-35.
3. Lewis EJ. The role of Angiotensin II receptor blockers in preventing the progression of renal disease in patients with type 2 diabetes. Am J Hypertens 2002;15(10 Pt 2):123S-128S.
4. Lansang MC, Price DA, Laffel LMB et al. Renal vascular responses to captopril and to candesartan in patients with Type 1 diabetes mellitus. Kidney Int 2001;59:1432-38.
5. Lohmeier TC. The sympathetic Nervous System and Long-Term Blood Pressure regulation. Am J Hypertens 2001; 14:147S-154S.
6. Lansang MC, Hollenberg NK. Renal perfusion and the renal hemodynamic response to blocking the renin system in diabetes: Are the forces leading to vasodilation and vasoconstriction linked? Diabetes 2002;51:2025-28.
7. Gordon MS, Price DA, Hollenberg NK. Blunted suppression of plasma renin activity in diabetes. JRAAS 2000; 1(3):252-6.
8. Price DA, Porter LE, Gordon MS et al. The Paradox of the Low-Renin State in Diabetic Nephropathy. J Am Soc Nephrol 1999;10:2382-91.
9. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Diabetes Care 2003;26: S1:S5-S20.
10. Fischer M, Baessler A, Schunkert A. Renin angiotensin system and gender differences in the cardiovascular system. Cardiovasc Res 2002;53(3):672-7.
11. Hollenberg NK, Meggs LG, Williams GH, Katz J, Garnic JD, Harrington DP. Sodium intake and renal responses to captopril in normal man and in essential hypertension. Kidney Int 1981;20:240-5.
12. Lansang MC, Osei SY, Price DA, Fisher NDL, Hollenberg NK. Renal Hemodynamic and Hormonal Responses to the Angiotensin II Antagonist Candesartan. Hypertension 2000; 36:834-8.
13. Belminute J, Levy BI, Michel JB: Changes in the renin-angiotensin-aldosterone axis in later life. Drugs Aging 1994;5(5):391-400.
14. Bauer JH. Age-related changes in the renin-aldosterone system: physiological effects and clinical implications. Drugs Aging 1993;3(3):238-45.
15. Hollenberg NK, Rivera A, Meinking T et al. Age, renal perfusion and function in island dwelling indigenous Kuna Amerinds of Panama. Nephron 1999;82(2):131-8.
16. Osei SY, Price DA, Fisher NDL, Porter L, Laffel LMB, Hollenberg NK. Hyperglycemia and Angiotensin-Mediated Control of the Renal Circulation in Healthy Humans. Hypertension 1999;33(part II):559-64.
17. Miller JA, Floras JS, Zinman B, Skorecki KL. Effect of hyperglycaemia on arterial pressure, plasma renin activity and renal function in early diabetes. Clin Sci 1996;90: 189-95.
18. Lansang MC, Osei SY, Coletti CM, Krupinski J, Hollenberg NK. Hyperglycemia-induced intrarenal RAS activation: the contribution of metabolic pathways. JRAAS 2002;3:19-23.
19. Burns KD, Homma T, Harris RC. The intrarenal renin-angiotensin system: Semin Nephrol 1993;13(1):13-30.
20. De'Oliveira JM, Price DA, Fisher NDL et al. Autonomy of the renin system in type II diabetes mellitus: Dietary and renal hemodynamic responses to ACE inhibition. Kidney Int 1997;52:771-7.
21. Hollenberg NK. The kidney and angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, and aldosterone antagonists. In: Therapy in Nephrology and Hypertension, 2nd edition, Companion to Brenner and Rector's The Kidney. Edited by HR Brady and CS Wilcox, Philadelphia, WB Saunders, 2003, pp.547-54.